
    
      This is a multicenter, randomized, double-blind, parallel group, vehicle-controlled, 12-week
      study to evaluate relative changes in inflammatory and non-inflammatory lesion counts, as
      well as treatment success using an Evaluator's Global Severity Scale (EGSS) in subjects with
      moderate to severe acne. IDP-121 is a lotion for the topical treatment of acne.
    
  